본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

The Role of B Cells in Transplantation and Immunopathic Diseases

Basten, A.    (Garvan Institute  );
  • 초록

    B cells, by virtue of their diverse roles in immune responses to foreign and self antigens, have become of increasing interest to the clinician as well as the basic immunologist. In particular, it is now apparent that the development of B cell unresponsiveness in antibody and T cell mediated autoimmune disorders and the transplant setting is both worthwhile and achievable.


  • 주제어

    B cells .   Transplantation .   Immunopathic diseases.  

  • 참고문헌 (37)

    1. Basten A, Brink R. Tolerance and Autoimmunity: B cells. In: Rose NR, Mackay IR, editors. The Autoimmune Diseases. 4th ed. St. Louis: Academic Press; p167-177, 2006 
    2. Goodnow CC: Multistep pathogenesis of autoimmune disease. Cell 130:25-35, 2007 
    3. von Boehmer H, Melchers F: Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol 11:14-20, 2010 
    4. von Boehmer H, Melchers F: Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol 11:14-20, 2010 
    5. Phan TG, Gray EE, Cyster JG: The microanatomy of B cell activation. Curr Opin Immunol 21:258-265, 2009 
    6. Cox SL, Silveira PA: Emerging roles for B lymphocytes in Type 1 diabetes. Expert Rev Clin Immu 5:311-324, 2009 
    7. Singh A, Carson WF 1th, Secor ER Jr, Guernsey LA, Flavell RA, Clark RB, Thrall RS, Schramm CM: Regulatory role of B cells in a murine model of allergic airway disease. J Immunol 180:7318-7326, 2008 
    8. Yanaba K, Bouaziz JD, Matsushita T, Magro CM, St Clair EW, Tedder TF: B-lymphocyte contributions to human autoimmune disease. Immunol Rev 223:284-299, 2008 
    9. DiLillo DJ, Matsushita T, Tedder TF: B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 1183:38-57, 2010 
    10. Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C: CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32:129-140, 2010 
    11. Skupsky J, Zhang AH, Su Y, Scott DW: B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells. Mol Ther 2010 [Epub ahead of print] 
    12. Silveira PA, Dombrowsky J, Johnson E, Chapman HD, Nemazee D, Serreze DV: B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol 172:5086-5094, 2004 
    13. Gavanescu I, Benoist C, Mathis D: B cells are required for Aire-deficient mice to develop multi-organ autoinflammation: a therapeutic approach for APECED patients. Pro Natl Acad Sci U S A 105:13009-13014, 2008 
    14. Browning JL: B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat Rev Drug Discov 5:564-576, 2006 
    15. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T: Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N EnglJ Med 350:2572-2581, 2004 
    16. Jacobi AM, Dorner T: Current aspects of anti-CD20 therapy in rheumatoid arthritis. Curr Opin Pharmacol 2010 [Epub ahead of print] 
    17. Lee YH, Bae SC, Song GG: The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials. Rheumatol Int 2010 [Epub ahead of print] 
    18. Merrill JT, Neuwelt CM, Wallace DJ, Shanahan JC, Latinis KM, Oates JC, Utset TO, Gordon C, Isenberg DA, Hsieh HJ, Zhang D, Brunetta PG: Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum 62:222-233, 2010 
    19. Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH, HERMES Trial Group: B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 358:676-688, 2008 
    20. Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, Trzaskoma B, Martin F, Agarwal S, Kelman A: Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum 62:64-74, 2010 
    21. Kessel A, Rosner I, Toubi E: Rituximab: beyond simple B cell depletion. Clin Rev Allergy Immunol 34:74-79, 2008 
    22. Marino E, Villanueva J, Walters S, Liuwantara D, Mackay F, Grey ST: CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells. Diabetes 58:1568-1577, 2009 
    23. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R, Gottlieb PA, Marks JB, McGee PF, Moran AM, Raskin P, Rodriguez H, Schatz DA, Wherrett D, Wilson DM, Lachin JM, Skyler JS, Type 1 Diabetes TrialNet Anti-CD20 Study Group: Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Eng J Med 361:2143-2152, 2009 
    24. Thaunat O, Morelon E, Defrance T: Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis. Blood 2010 [Epub ahead of print] 
    25. Ratanatharathorn V, Pavletic S, Uberti JP: Clinical applications of rituximab in allogeneic stem cell transplantation: anti- tumor and immunomodulatory effects. Cancer Treat Rev 35:653-661, 2009 
    26. Guidelines for clinical usage of intravenous immunoglobulin IVIg in Australia. National Blood Authority, Australia. pp 160-165, 2008 
    27. Parsons RF, Vivek K, Redfield RR, Migone TS, Cancro MP, Naji A, Noorchashm H: B-cell tolerance in transplantation: is repertoire remodeling the answer? Expert Rev Clin Immunol 5:703, 2009 
    28. Fan X, Ang A, Pollock-Barziv SM, Dipchand AI, Ruiz P, Wilson G, Platt JL, West LJ: Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 10:1227-1233, 2004 
    29. Gibbons C, Sykes M: Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism. Immunol Rev 223:334-360, 2008 
    30. Zarkhin V, Kambham N, Li L, Kwok S, Hsieh SC, Salvatierra O, Sarwal MM: Characterization of intra-graft B cells during renal allograft rejection. Kidney Int 74:664-673, 2008 
    31. Zarkhin V, Li L, Kambham N, Sigdel T, Salvatierra O, Sarwal MM: A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation. Am J Transplant 8:2607-2617, 2008 
    32. Liu C, Noorchashm H, Sutter JA, Naji M, Prak EL, Boyer J, Green T, Rickels MR, Tomaszewski JE, Koeberlein B, Wang Z, Paessler ME, Velidedeoglu E, Rostami SY, Yu M, Barker CF, Naji A: B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat Med 13:1295-1298, 2007 
    33. Terasaki PI, Ozawa M, Castro R: Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 7:408-415, 2007 
    34. Turka LA, Lechler RI: Towards the identification of biomarkers of transplantation tolerance. Nat Rev Immunol 9:521-526, 2009 
    35. Barnett JC, Bean SM, Whitaker RS, Kondoh E, Baba T, Fujii S, Marks JR, Dressman HK, Murphy SK, Berchuck A: Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype. Gynecol Oncol 116: 556-562, 2010 
    36. Xu L, Xu W, Qiu S, Xiong S: Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer. Clin Immunol 135:466-475, 2010 
    37. Zhang HH, Mei MH, Fei R, Liao WJ, Wang XY, Qin LL, Wang JH, Wei L, Chen HS: Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro. Int J Oncol 36:841-848, 2010 

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기